Align Technology, Inc. (“Align”) (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Citibank, N.A. (“Citi”), to repurchase $250 million of Align’s common stock under Align’s $1.0 billion stock repurchase program announced on May 13, 2021.
Related Posts
Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday.
The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52. The S&P 500 also rose, gaining, 0.25% to 4,384.43.
Bunge Boosts FY22 EPS Outlook Citing Solid Q2 Results, Current Market Environment
Bunge Ltd (NYSE:BG) reported second-quarter FY22 sales growth of 16.5% year-on-year, to $17.93 billion, beating the consensus of $16.81 billion. Net sales…
Keybanc Maintains Overweight on F5, Lowers Price Target to $182
Keybanc analyst Thomas Blakey maintains F5 (NASDAQ:FFIV) with a Overweight and lowers the price target from $190 to $182.